Geode Capital Management’s Xenetic Biosciences XBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding XBIO
Geode Capital Management's XBIO Position: Q3 2026 in Review
Geode Capital Management held its Xenetic Biosciences (XBIO) position steady in Q3 2026 at 17,423 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4241.
Geode Capital Management first reported a position in XBIO in Q4 2020 and has held it in 23 quarters since. The position peaked at $213K in Q3 2021. 12 funds tracked by Wall St. Rank hold XBIO as of Q3 2026.
- Geode Capital Management held 17,423 shares of Xenetic Biosciences worth $40.4K as of Q3 2026.
- Geode Capital Management left its Xenetic Biosciences share count unchanged in Q3 2026.
- Xenetic Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4241 holding.
- Geode Capital Management first reported a position in Xenetic Biosciences in Q4 2020 and has held it in 23 quarters since.
- Geode Capital Management's Xenetic Biosciences position peaked at $213K in Q3 2021.
- 12 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.